Literature DB >> 17707558

Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques.

Bernard Metz1, Wim Jiskoot, Dirk Mekkes, Robert Kingma, Wim E Hennink, Daan J A Crommelin, Gideon F A Kersten.   

Abstract

Physicochemical and immunochemical techniques can be used to assess the quality of diphtheria toxoid vaccines. In a previous paper [Metz B, Jiskoot W, Hennink WE, Crommelin DJA, Kersten GFA. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine 2003;22(2):156-67], techniques were introduced which indicated toxoid quality with respect to safety and potency: SDS-PAGE, primary amino group determination, fluorescence/denaturation, circular dichroism and biosensor analyses. These analyses were performed with experimental toxoids from one toxin batch. In the present study, the quality of regular vaccine batches of different manufacturers, the properties of real-time aged products and a number of experimental toxoids were investigated, using the above-mentioned analytical techniques. We had the unique opportunity to analyse toxoids that were up to 40 years old. The real-time aged diphtheria toxoids showed hardly any structural differences as compared to the recently prepared products in both the analytical chemical techniques and the conventional potency and safety tests. The analytical assays discriminated between regular diphtheria toxoids and experimental toxoids prepared by methylation, acetylation or glutaraldehyde treatment. The analytical data showed a clear correlation with potency and safety of these toxoids. Based on the results, we refined the described physicochemical and immunochemical criteria that a standard diphtheria toxoid has to meet. We recommend further validation of these techniques for quality control of diphtheria toxoid vaccine because of their high precision and easy performance as compared to conventional in vivo procedures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707558     DOI: 10.1016/j.vaccine.2007.07.009

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid.

Authors:  Pieter G M van Gageldonk; Christina von Hunolstein; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Biophysical comparison of diphtheria and tetanus toxins with the formaldehyde-detoxified toxoids, the main components of diphtheria and tetanus vaccines.

Authors:  Husam Alsarraf; Emil Dedic; Morten J Bjerrum; Ole Østergaard; Max Per Kristensen; Jesper W Petersen; René Jørgensen
Journal:  Virulence       Date:  2017-05-16       Impact factor: 5.882

3.  Combination vaccines.

Authors:  David Ag Skibinski; Barbara C Baudner; Manmohan Singh; Derek T O'Hagan
Journal:  J Glob Infect Dis       Date:  2011-01

4.  Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.

Authors:  Shaimaa Abulmagd; Abd El-Nasser A Khattab; Hamdallah Zedan
Journal:  Clin Exp Vaccine Res       Date:  2022-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.